Cargando…

Vaccine Formulation for Infectious Diseases and Adjuvant Mechanisms of Action

Detalles Bibliográficos
Autores principales:	Wilson, Heather L., Haddadi, Azita, Mutwiri, George K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235003/ https://www.ncbi.nlm.nih.gov/pubmed/34207033 http://dx.doi.org/10.3390/vaccines9060667

Ejemplares similares

Mechanisms of Action of Adjuvants
por: Awate, Sunita, et al.
Publicado: (2013)

Polyphosphazenes as Adjuvants for Animal Vaccines and Other Medical Applications
por: Chand, Dylan J., et al.
Publicado: (2021)

Combination of Innate Immune Modulators as Vaccine Adjuvants in Mice
por: Haddadi, Azita, et al.
Publicado: (2020)

Vaccines and Vaccine Adjuvants for Infectious Diseases and Autoimmune Diseases
por: Nandakumar, Kutty Selva
Publicado: (2023)

THEME: “Vaccines and Vaccine Adjuvants/Immunomodulators for Infectious Diseases”
por: Retnakumar, Sruthi Vijaya, et al.
Publicado: (2023)

Kinome Analysis to Define Mechanisms of Adjuvant Action: PCEP Induces Unique Signaling at the Injection Site and Lymph Nodes
por: Awate, Sunita, et al.
Publicado: (2022)

The Adjuvants Polyphosphazene (PCEP) and a Combination of Curdlan Plus Leptin Promote a Th17-Type Immune Response to an Intramuscular Vaccine in Mice
por: Chaffey, Alyssa, et al.
Publicado: (2021)

Editorial: Engineered Adjuvants and Carriers for an Animal Infectious Disease Vaccine
por: Renu, Sankar, et al.
Publicado: (2021)

Vaccine Potentiation by Combination Adjuvants
por: Levast, Benoît, et al.
Publicado: (2014)

Experimental PCEP-Adjuvanted Swine Influenza H1N1 Vaccine Induced Strong Immune Responses but Did Not Protect Piglets against Heterologous H3N2 Virus Challenge
por: Magiri, Royford Bundi, et al.
Publicado: (2020)

Advances in Infectious Disease Vaccine Adjuvants
por: Fan, Jingyi, et al.
Publicado: (2022)

Investigation and optimization of formulation parameters on preparation of targeted anti-CD205 tailored PLGA nanoparticles
por: Jahan, Sheikh Tasnim, et al.
Publicado: (2015)

Recent Advances of Vaccine Adjuvants for Infectious Diseases
por: Lee, Sujin, et al.
Publicado: (2015)

Next Generation Vaccines for Infectious Diseases
por: Sautto, Giuseppe A., et al.
Publicado: (2019)

Vaccines against Infectious Diseases and Cancer
por: Sousa, Ângela, et al.
Publicado: (2022)

Bacillus subtilis Spores as Vaccine Adjuvants: Further Insights into the Mechanisms of Action
por: de Souza, Renata Damásio, et al.
Publicado: (2014)

Non-Invasive Vaccines: Challenges in Formulation and Vaccine Adjuvants
por: Han, Sumin, et al.
Publicado: (2023)

Novel Vaccine Adjuvants
por: Agrawal, Anshu, et al.
Publicado: (2013)

Arenaviral vaccine vectors to combat infectious diseases
por: Dhanwani, Rekha, et al.
Publicado: (2016)

Vaccine Adjuvants: Mode of Action
por: De Gregorio, Ennio, et al.
Publicado: (2013)

Natural and synthetic carbohydrate-based vaccine adjuvants and their mechanisms of action
por: Pifferi, Carlo, et al.
Publicado: (2021)

TLR Agonists as Vaccine Adjuvants Targeting Cancer and Infectious Diseases
por: Luchner, Marina, et al.
Publicado: (2021)

Vaccine adjuvant materials for cancer immunotherapy and control of infectious disease
por: Lim, Yong Taik
Publicado: (2015)

Comparative tissue proteomics reveals unique action mechanisms of vaccine adjuvants
por: Li, Yibo, et al.
Publicado: (2022)

Human prophylactic vaccine adjuvants and their determinant role in new vaccine formulations
por: Pérez, O., et al.
Publicado: (2012)

Modes of Action for Mucosal Vaccine Adjuvants
por: Aoshi, Taiki
Publicado: (2017)

Molecular therapies and vaccines face the challenges of emerging infectious diseases
por: Patel, Ami, et al.
Publicado: (2022)

Oral antigen exposure in newborn piglets circumvents induction of oral tolerance in response to intraperitoneal vaccination in later life
por: Pasternak, J Alex, et al.
Publicado: (2015)

Immunoglobulin: production, mechanisms of action and formulations
por: Novaretti, Marcia Cristina Zago, et al.
Publicado: (2011)

Intranasal Delivery of Influenza Subunit Vaccine Formulated with GEM Particles as an Adjuvant
por: Saluja, Vinay, et al.
Publicado: (2010)

Editorial: Advances in Vaccine Delivery: Adjuvants, Carriers, Formulations, and Routes
por: Skwarczynski, Mariusz
Publicado: (2022)

Advancements in Vaccine Adjuvants: The Journey from Alum to Nano Formulations
por: Moni, Sivakumar S., et al.
Publicado: (2023)

The mechanisms of action of vaccines containing aluminum adjuvants: an in vitro vs in vivo paradigm
por: Ghimire, Tirth Raj
Publicado: (2015)

Neglected Infectious Diseases: Mechanism of Pathogenesis, Diagnosis, and Immune Response
por: Romero, Eliete Caló, et al.
Publicado: (2012)

Using Adjuvants to Drive T Cell Responses for Next-Generation Infectious Disease Vaccines
por: Rapaka, Rekha R., et al.
Publicado: (2021)

Nano and Microparticles as Potential Oral Vaccine Carriers and Adjuvants Against Infectious Diseases
por: Jazayeri, Seyed Davoud, et al.
Publicado: (2021)

Immunobiology of Carbohydrates: Implications for Novel Vaccine and Adjuvant Design Against Infectious Diseases
por: Stefanetti, Giuseppe, et al.
Publicado: (2022)

The combination of vaccines and adjuvants to prevent the occurrence of high incidence of infectious diseases in bovine
por: Yao, Yiyang, et al.
Publicado: (2023)

Caspase-1 Dependent IL-1β Secretion and Antigen-Specific T-Cell Activation by the Novel Adjuvant, PCEP
por: Awate, Sunita, et al.
Publicado: (2014)

A Single-Dose Intramuscular Nanoparticle Vaccine With or Without Prior Intrauterine Priming Triggers Specific Uterine and Colostral Mucosal Antibodies and Systemic Immunity in Gilts but Not Passive Protection for Suckling Piglets
por: Choudhary, Pooja, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_93ipr326bdalg71mp39retmtk6